Literature DB >> 6654046

Lysozyme content of tears in normal subjects and in patients with external eye infections.

K M Saari, E Aine, A Posz, M Klockars.   

Abstract

We studied the lysozyme content of tears in 267 subjects (521 eyes), including 241 healthy subjects, 7 patients (14 eyes) with bilateral blepharitis, 8 patients (12 eyes) with conjunctivitis, and 11 patients (16 eyes) with keratitis. The concentration of lysozyme in the tears rises with age between childhood and maturity. The highest values were seen in the age group of 21-40 years, and a decrease of lysozyme concentration occurred with an increase in age from 30-40 years. The mean lysozyme content of tears was 1,768 micrograms/ml in healthy subjects; no significant differences occurred between the sexes. Patients with blepharitis, conjunctivitis, and keratitis had normal mean lysozyme content of tears. The tears of patients with herpes simplex keratitis had low lysozyme values.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6654046     DOI: 10.1007/BF02133813

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

1.  Quantitative tear lysozyme assay in units of activity per microlitre.

Authors:  I A Mackie; D V Seal
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

Review 2.  Resistance to infection of the external eye: the role of tears.

Authors:  D S Selinger; R C Selinger; W P Reed
Journal:  Surv Ophthalmol       Date:  1979 Jul-Aug       Impact factor: 6.048

3.  Influence of malnutrition on the concentration of IgA, lysozyme, amylase and aminopeptidase in children's tears.

Authors:  R R Watson; M A Reyes; D N McMurray
Journal:  Proc Soc Exp Biol Med       Date:  1978-02

4.  Diurnal profiles of tear lysozyme and gamma A globulin.

Authors:  B L Horwitz; G R Christensen; S R Ritzmann
Journal:  Ann Ophthalmol       Date:  1978-01

5.  Tissue distribution of lysozyme in man.

Authors:  M Klockars; S Reitamo
Journal:  J Histochem Cytochem       Date:  1975-12       Impact factor: 2.479

Review 6.  Clinical biochemistry of tears.

Authors:  N J Van Haeringen
Journal:  Surv Ophthalmol       Date:  1981 Sep-Oct       Impact factor: 6.048

7.  Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.

Authors:  I A Mackie; D V Seal; J M Pescod
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

8.  Immunoassay of tear lysozyme in conjunctival diseases.

Authors:  D K Sen; G S Sarin
Journal:  Br J Ophthalmol       Date:  1982-11       Impact factor: 4.638

9.  Lysozyme content of tears in patients with Sjögren's syndrome and rheumatoid arthritis.

Authors:  R Avisar; R Menaché; P Shaked; J Rubinstein; I Machtey; H Savir
Journal:  Am J Ophthalmol       Date:  1979-02       Impact factor: 5.258

10.  Basal and reflex human tear analysis. II. Chemical analysis: lactoferrin and lysozyme.

Authors:  R N Stuchell; R L Farris; I D Mandel
Journal:  Ophthalmology       Date:  1981-08       Impact factor: 12.079

View more
  3 in total

1.  Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjects.

Authors:  Heikki Peuravuori; Valtteri V Aho; Heikki J Aho; Yrjö Collan; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

2.  Lysozyme Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Inflammation in Human Corneal Epithelial Cells.

Authors:  Yinting Song; Haokun Zhang; Yanfang Zhu; Xiao Zhao; Yi Lei; Wei Zhou; Jinguo Yu; Xue Dong; Xiaohong Wang; Mei Du; Hua Yan
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

3.  Corneal Expression of SLURP-1 by Age, Sex, Genetic Strain, and Ocular Surface Health.

Authors:  Sudha Swamynathan; Emili E Delp; Stephen A K Harvey; Chelsea L Loughner; Leela Raju; Shivalingappa K Swamynathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.